Pharmacy & Distribution Market Research Reports & Industry Analysis
The U.S. two-class system is divided into prescription and nonprescription, or over-the-counter (OTC), medicines. The advantage is that OTC medicines are conveniently sold in a number of retail outlets so that medicines are available when consumers need them. This emphasis on consumer empowerment directly serves two of the most fundamental demands of any workable health care system -- access and affordability.
In recent years, a few of the world’s pharmacy-only national systems have recognized the growing need for greater access to safe and effective medications. Japan, the Netherlands, Denmark, the United Kingdom, Italy, and Argentina all have been part of this trend toward granting consumers increased access to medicines in more outlets.
The drug distribution system in the U.S. is highly regulated by the U.S. Food and Drug Administration (FDA) to ensure only those medications that have a wide enough safety margin and that can be safely and effectively used without the help of a health care professional are available without a prescription.
The somewhat controversial notion of adding a third class of drugs to the U.S. system has been panned by experts and regulators including the AMA and FDA. They say creating a third transition class of drugs would create another health care-disadvantaged population -- those without easy access to a pharmacist at convenient times.
Pharmacy & Distribution Industry Research & Market Reports
-
Scleroderma Treatment Market Size, Trends, Analysis, and Outlook By Therapeutics (Drug Therapy, Hematopoietic Stem Cell Transplantation (HSCT)), By Indication (Limited Cutaneous Systemic Sclerosis Lamotrigine, Diffuse Cutaneous Systemic Sclerosis), By Target Organ (Skin Fibrosis, Musculoskeletal, Digital Ulcers, Pulmonary Arterial Hypertension, Gastrointestinal, Pulmonary Fibrosis, Scleroderma Renal Crisis), By Route of Administration (Injectable, Oral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Ulcers, Pulmonary Arterial Hypertension, Gastrointestinal, Pulmonary Fibrosis, Scleroderma Renal Crisis), By Route of Administration (Injectable, Oral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics), by Region, Country, Segment, and Companies, 2024-2030 ... Read More
-
Canine Arthritis Treatment Market Size, Trends, Analysis, and Outlook By Type (Surgery, Drugs, Others), By Route of Administration (Oral, Parenteral, Others), By Treatment (Non-steroidal anti-inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells, Autologous Stem Cells), By End-User (Hospitals, Speciality Clinics, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Stem Cells), By End-User (Hospitals, Speciality Clinics, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Canine Arthritis Treatment market size is poised to register 6.84% ... Read More
-
Safety Needles Market Size, Trends, Analysis, and Outlook By Product (Fine Aspiring Needles, Biopsy Needles, Hypodermic Needles, Pen Needles, Suture Needles, IV Catheter Needles, Blood Collection Needles, Spinal Anesthesia and Epidural Needles, Prefilled Needles, A.V. Fistula, Cannula Needles, Huber Needles), By Application (Sample Collection, Drug Delivery), By Distribution Channel (Hospitals Pharmacies, Private Clinics, Retail Pharmacies & Drug Stores, E-commerce), by Region, Country, Segment, and Companies, 2024-2030
... Fistula, Cannula Needles, Huber Needles), By Application (Sample Collection, Drug Delivery), By Distribution Channel (Hospitals Pharmacies, Private Clinics, Retail Pharmacies & Drug Stores, E-commerce), by Region, Country, Segment, and Companies, 2024-2030 The global Safety Needles ... Read More
-
Transthyretin Amyloidosis Treatment Market - By Type (ATTR-CM, ATTR-PN), Disease Type (Hereditary, Wild Type), Drug Type (Tafamidis, Patisiran), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Drug Store) - Global Forecast 2024 - 2032
... 2032 Transthyretin amyloidosis treatment market size is expected to witness 7.5% CAGR between 2024 and 2032, driven by the advancements in medical research and technologies. Lately, several therapeutic innovations are offering promising outcomes in halting ... Read More
-
India Traditional Medicine Market Assessment, By System of Medicine [Ayurveda, Yoga, Naturopathy, Unani, Siddha, Homeopathy], By Sub-sectors [Herbal Plants, Nutraceuticals, Cosmeceuticals, Pharmaceuticals, Plant Derivatives, Plant Extracts], By Source [Plants, Animals, Metals, Minerals], By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Respiratory, Diabetology, Others], By Route of Administration [Oral Route, Nasal Route, Ocular Route, Otic Route, Cutaneous Route, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, By Opportunities and Forecast, FY2017-FY2031F
... Cardiovascular, Dermatology, Oncology, Respiratory, Diabetology, Others], By Route of Administration [Oral Route, Nasal Route, Ocular Route, Otic Route, Cutaneous Route, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, By Opportunities and ... Read More
-
Vietnam Pneumococcal Vaccine Market Assessment, By Type of Vaccine [Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Recombinant Vaccines], By Vaccine Property [Adjuvanted, Non-adjuvanted], By Route of Administration [Intramuscular, Subcutaneous, Intradermal, Others], By Age Group [Infants, Children, Adults], By End-user [Hospitals, Specialty Clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy, Non-Governmental Organizations], By Region, By Opportunities and Forecast, 2017-2031F
... Children, Adults], By End-user [Hospitals, Specialty Clinics, Homecare, Others], By Distribution Channel [Hospital, Retail Pharmacy, Online Pharmacy, Non-Governmental Organizations], By Region, By Opportunities and Forecast, 2017-2031F Vietnam pneumococcal vaccine market is projected to witness a ... Read More
-
Glucose Monitoring System Market Assessment, By Type [Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems], By Component [Glucometer Devices, Test Strips, Lancets, Sensors, Durables], By Product [Devices, Services], By Patient Care Setting [Hospital, Homecare], By Application [Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes], By Modality [Wearable, Non-wearable], By Invasiveness [Invasive Methods, Minimally Invasive Methods, Non-Invasive Methods], By Distribution Channel [Retail Stores, E-commerce, Pharmacy], By Region, By Opportunities and Forecast, 2017-2031F
... Application [Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes], By Modality [Wearable, Non-wearable], By Invasiveness [Invasive Methods, Minimally Invasive Methods, Non-Invasive Methods], By Distribution Channel [Retail Stores, E-commerce, Pharmacy], By Region, By Opportunities and Forecast, ... Read More
-
Acute Ocular Pain Market Assessment, By Drug [Topical NSAIDs, Topical Cycloplegic Agents, Oral Analgesics, Corticosteroids, Immunomodulators], By Medical Condition [Corneal Abrasion, Glaucoma, Conjunctivitis, Iritis, Others], By Route of Administration [Topical, Periocular, Intraocular, Oral, Others], By Distribution Channel [Hospital Pharmacy, Online Pharmacy, Retail Pharmacy], By End-user [Hospitals, Homecare, Ophthalmic Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F
... Distribution Channel [Hospital Pharmacy, Online Pharmacy, Retail Pharmacy], By End-user [Hospitals, Homecare, Ophthalmic Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F Global acute ocular pain market is projected to witness a CAGR of 8.93% during ... Read More
-
Infectious Vaccines Market Size, Trends, Analysis, and Outlook By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others), By Disease(Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Vaccines market size is poised to register 6.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Thalassemia Market Size, Trends, Analysis, and Outlook By Treatment Type (Iron Chelation Therapy, Others), By Type (Alpha Thalassemia, Beta Thalassemia), By Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Thalassemia market size is poised to register 10.51% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Medication Management System Market Size, Trends, Analysis, and Outlook By Software (Computerized Physician Order, Clinical Decision Support System Solutions, Inventory Management Software, Administration Software, Automated Dispensing Systems), By Services (Medication Analytics, Point-of-Care Verification, ADE Surveillance), By Mode of Delivery (On-premises, Web-based, Cloud-based), By End-user (Hospitals, Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... By Mode of Delivery (On-premises, Web-based, Cloud-based), By End-user (Hospitals, Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Medication Management System market size is poised to register 12.9% growth from 2024 to ... Read More
-
Telepharmacy Market Size, Trends, Analysis, and Outlook By Services (Patient Counseling, Remote Dispensing, Drug Therapy Monitoring, Refill Authorization for Prescription Drugs), By Delivery Mode (On-premises, Web-based, Cloud-based), by Region, Country, Segment, and Companies, 2024-2030
... global Telepharmacy market size is poised to register 21.81% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Telepharmacy market across By Services ... Read More
-
Psychedelic Drugs Market Size, Trends, Analysis, and Outlook By Drug Type (Gamma Hydroxybutyric Acid (GHB), Ketamine, Psilocybin, Lysergic Acid Diethylamide (LSD), 3,4-MethylEnedioxyMethamphetamine, Others), By Application (Treatment Resistant Depression, Opiate Addiction, Post-traumatic Stress Disorder, Narcolepsy, Panic Disorders, Others), By Distribution Channel, Hospital pharmacy, Retail pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disorders, Others), By Distribution Channel, Hospital pharmacy, Retail pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Psychedelic Drugs market size is poised to register 13.57% growth from 2024 to 2030, presenting significant ... Read More
-
Retinal Disorder Treatment Market Size, Trends, Analysis, and Outlook By Type (Macular Degeneration, Diabetic Retinopathy, Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Retinal Disorder Treatment market size is poised to register 9.7% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Cardiovascular Health Supplements Market Size, Trends, Analysis, and Outlook By Type (Natural Supplements, Synthetic Supplements), By Ingredient (Vitamins & Minerals, Herbs & Botanicals, Omega Fatty Acids, Coenzyme Q10 (CoQ10), Others), By Form (Liquid, Tablet, Capsules, Softgels, Powder, Others), By Distribution Channel (Offline, Online), by Region, Country, Segment, and Companies, 2024-2030
... Softgels, Powder, Others), By Distribution Channel (Offline, Online), by Region, Country, Segment, and Companies, 2024-2030 The global Cardiovascular Health Supplements market size is poised to register 8.71% growth from 2024 to 2030, presenting significant growth ... Read More
-
Schizophrenia Drugs Market Size, Trends, Analysis, and Outlook By Treatment (Oral, Injectable), By Therapeutic Class (Second-Generation Antipsychotics (Risperdal, Invega, Zyprexa, Geodon, Seroquel, Latuda, Aristada, Fanapt, Saphris, Vraylar), Third-Generation Antipsychotics, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Schizophrenia Drugs market size is poised to register 5.41% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Intranasal Drug and Vaccine Delivery Market Size, Trends, Analysis, and Outlook By Product (Powder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler, Others), By Dosage Form (Unit-dose, Multi-dose), By Application (Respiratory disorders, Neurological disorders, Vaccination, Pain Management, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Vaccination, Pain Management, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Intranasal Drug and Vaccine Delivery market size is poised to register 6.46% growth ... Read More
-
Sarcoma Drugs Market Size, Trends, Analysis, and Outlook By Treatment Type (Chemotherapy, Targeted therapy & Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Drugs market size is poised to register 9.14% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Sarcoma Drugs market across By Treatment ... Read More
-
Vulvovaginal Candidiasis Treatment Market Size, Trends, Analysis, and Outlook By Drug Class (Clotrimazole, Nystatin, Fluconazole, Ketoconazole, Terbinafine, Terconazole, Others), By Route of Administration (Oral, Intravenous, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... by Region, Country, Segment, and Companies, 2024-2030 The global Vulvovaginal Candidiasis Treatment market size is poised to register 4.66% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Opioid Use Disorder Market Size, Trends, Analysis, and Outlook By Drug (Buprenorphine, Methadone, Naltrexone), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies & Stores), by Region, Country, Segment, and Companies, 2024-2030
... and Companies, 2024-2030 The global Opioid Use Disorder market size is poised to register 10.42% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Anorexiants Market Size, Trends, Analysis, and Outlook By Route of Administration (Subcutaneous Anorexiants, Oral Anorexiants), By Distribution Channel ( Online Pharmacy, Retail Pharmacy, Hospital Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... market size is poised to register 5.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Anorexiants market across By Route of Administration ... Read More
-
Human Growth Hormone Market Size, Trends, Analysis, and Outlook By Product (Long Acting, Others), By Application (Growth Hormone (GH) Deficiency, Adult GH Deficiency, Pediatric GH Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Gestational Age, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Human Growth Hormone market size is poised to register 11.73% growth from ... Read More
-
Europe Breast Cancer Therapeutics Market Forecast to 2030 - Regional Analysis - by Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies)
... Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies) The ... Read More
-
Antibiotic Resistance Market Size, Trends, Analysis, and Outlook By Disease (Complicated Urinary Tract Infections, Clostridioides difficile Infection, Acute bacterial skin and skin structure infections, Hospital-acquired bacterial pneumonia, Community-acquired pneumonia, Complicated intra-abdominal infection, Bloodstream infection), By Pathogen, E. coli, K. pneumoniae, P. aeruginosa, S. aureus, A. baumannii, S. pneumoniae, H. influenzae, C. difficile, E. faecium), By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination therapies, Cephalosporins, Others), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Pathogen, E. coli, K. pneumoniae, P. aeruginosa, S. aureus, A. baumannii, S. pneumoniae, H. influenzae, C. difficile, E. faecium), By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination therapies, Cephalosporins, Others), By Mechanism of Action (Protein Synthesis ... Read More
-
Influenza Medications Market Size, Trends, Analysis, and Outlook By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Distribution Channel ( Hospital Pharmacy, Independent Pharmacy and Drug Store, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... The global Influenza Medications market size is poised to register 5.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Influenza Medications market ... Read More
Research Assistance
